SES Capital

SES Capital is a private investment firm that provides financing and strategic capital to companies within the life sciences and healthcare sectors. The firm is notably recognized for providing a $10 million revolving credit facility to Signalife (now HeartSentry), a medical technology company focused on continuous biomedical signal monitoring and cardiac disease detection. SES Capital typically engages in structured financing, including credit lines and equity-linked investments, to support the commercialization and market entry of medical devices and healthcare solutions. While primarily an investment vehicle, its activities are deeply integrated with the growth and funding of emerging biotechnology and medtech enterprises.